Figure 5From: Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagyEffect of celecoxib on cell apoptosis. Cells were treated with celecoxib (8 and 30 μM) for 72 hours. In some cases, U87MG cells were pre-treated with PFT (25 μM) prior to celecoxib treatment. Cells were collected and stained with Annexin V-FITC and propidium iodide, followed by FACS analysis. Percentage population of early apoptosis (lower right quadrant) and late apoptosis (upper right quadrant) in celecoxib-treated U87MG and U87MG-E6 cells, stained with Annexin-FITC and propidium iodide are shown (A). Summary quantitative analyses of total apoptosis population following celecoxib treatment are presented (B-C). Values are expressed as mean ± S.E.M., n = 3–6. *P < 0.05, significantly different from respective controls (1-way ANOVA, Dunnett's test). #P < 0.05, significantly different between PFT-treated and -untreated U87MG cells (Mann-Whitney U-test).Back to article page